|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.81 USD | +13.58% |
|
+17.95% | -8.42% |
| 07-31 | Dolby Laboratories, Inc., Q3 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Dolby Laboratories Fiscal Q3 Adjusted Earnings, Revenue Fall | MT |
Company Valuation: Dolby Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 9,375 | 6,589 | 7,494 | 7,231 | 6,938 | 5,509 | - | - |
| Change | - | -29.72% | 13.74% | -3.51% | -4.05% | -20.6% | - | - |
| Enterprise Value (EV) | 8,103 | 5,772 | 7,494 | 7,231 | 6,938 | 5,509 | 5,509 | 5,509 |
| Change | - | -28.77% | 29.85% | -3.51% | -4.05% | -20.6% | 0% | 0% |
| P/E | 31.1x | 37.3x | 38.2x | 28.2x | 27.6x | 19x | 16.6x | 15.9x |
| PBR | 3.6x | 2.88x | - | - | 2.65x | 2.1x | - | - |
| PEG | - | -1x | 2.9x | 0.9x | -10.61x | 1.1x | 1.1x | 3.89x |
| Capitalization / Revenue | 7.32x | 5.26x | 5.77x | 5.68x | 5.14x | 3.89x | 3.74x | 3.55x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.89x | 3.74x | 3.55x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 10.1x | 9.67x | 8.87x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 18.2x | 16.2x | 13.6x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 13.3x | 11.2x | 10.2x |
| FCF Yield | 4.2% | 4.11% | 4.49% | 4.11% | 6.28% | 7.51% | 8.94% | 9.79% |
| Dividend per Share 2 | 0.91 | 1.02 | 1.11 | - | 1.32 | - | - | - |
| Rate of return | 0.98% | 1.51% | 1.42% | - | 1.82% | - | - | - |
| EPS 2 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 | 3.092 | 3.545 | 3.69 |
| Distribution rate | 30.6% | 56.4% | 54.1% | - | 50.4% | - | - | - |
| Net sales 1 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 | 1,417 | 1,472 | 1,550 |
| EBITDA 1 | 550.2 | 420.6 | 463.9 | 460.1 | 496.3 | 547.1 | 569.6 | 621.2 |
| EBIT 1 | 344.4 | 206.6 | 215.8 | 258.3 | 265 | 302.5 | 339.2 | 404.7 |
| Net income 1 | 310.2 | 184.1 | 200.7 | 261.8 | 255 | 255.7 | 292.3 | 349 |
| Net Debt | -1,272 | -817.6 | - | - | - | - | - | - |
| Reference price 2 | 92.47 | 67.46 | 78.36 | 75.84 | 72.39 | 58.81 | 58.81 | 58.81 |
| Nbr of stocks (in thousands) | 101,387 | 97,677 | 95,641 | 95,348 | 95,844 | 93,669 | - | - |
| Announcement Date | 16/11/21 | 17/11/22 | 16/11/23 | 19/11/24 | 18/11/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.02x | - | - | - | 5.51B | |
| -353.18x | 6.67x | 24.9x | -.--% | 24.45B | |
| 148.49x | 0.8x | 11.07x | -.--% | 7.16B | |
| 80.48x | 1.66x | 11.89x | -.--% | 3.74B | |
| 23.75x | 2.36x | 11.44x | 1.4% | 1.71B | |
| 21.36x | - | - | - | 430M | |
| 131.64x | 4.62x | 14.94x | - | 380M | |
| Average | 10.22x | 3.22x | 14.85x | 0.35% | 6.2B | |
| Weighted average by Cap. | -162.91x | 4.83x | 20.24x | 0.06% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DLB Stock
- Valuation Dolby Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
